Codes / CPT4 / 81260

81260 IKBKAP (inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase complex-associated protein) (eg, familial dysautonomia) gene analysis, common variants (eg, 2507+6T>C, R696P)

CPT4 code

CPT4

Name of the Procedure:

IKBKAP Gene Analysis (e.g., Familial Dysautonomia) – Analysis of Common Variants (e.g., 2507+6T>C, R696P)

Summary

This genetic test examines specific variants of the IKBKAP gene known to be associated with familial dysautonomia, a rare genetic disorder affecting the autonomic and sensory nervous systems.

Purpose

The procedure aims to:

  • Confirm a diagnosis of familial dysautonomia.
  • Identify carriers of the IKBKAP gene mutations.
  • Provide information for family planning or genetic counseling.

Indications

  • Symptoms of familial dysautonomia such as poor muscle tone, feeding difficulties, lack of tears, and frequent infections.
  • Family history of familial dysautonomia.
  • Couples considering having children, where one or both partners are of Ashkenazi Jewish descent.

Preparation

  • No specific preparation required.
  • Patients may be advised to provide a detailed family medical history.
  • Sometimes a blood draw might be scheduled; patients should follow routine blood draw preparation instructions (e.g., hydrate well).

Procedure Description

  1. Sample Collection: A blood sample is typically collected from the patient.
  2. DNA Extraction: The sample is sent to a lab where DNA is extracted.
  3. Genetic Analysis: The DNA is analyzed for the specific common variants 2507+6T>C and R696P in the IKBKAP gene using techniques like PCR (Polymerase Chain Reaction) and sequencing.
  4. Results Interpretation: Results are interpreted by a geneticist who will provide a detailed report outlining whether the mutations are present.

Duration

The blood draw takes a few minutes, but the entire analysis process can take several weeks for results.

Setting

Performed in genetic testing laboratories, with the initial blood draw often conducted in a physician’s office, hospital, or outpatient clinic.

Personnel

  • Phlebotomist or nurse for blood draw.
  • Geneticists and lab technicians for the DNA analysis.
  • Genetic counselor or physician for delivering and explaining the results.

Risks and Complications

  • Minimal risks from the blood draw, including slight bleeding or bruising at the puncture site.
  • Rarely, emotional distress if results indicate a genetic disorder.

Benefits

  • Accurate diagnosis, aiding in better management and treatment of familial dysautonomia.
  • Informed family planning decisions.
  • Genetic counseling for at-risk family members.

Recovery

  • No recovery period needed for blood draw.
  • Emotional and psychological support may be needed depending on test results.

Alternatives

  • Other genetic tests may examine a broader range of mutations but may not be as focused.
  • Clinical diagnosis based on symptoms and family history without genetic confirmation, although less definitive.

Patient Experience

  • Blood draw involves brief, minimal discomfort.
  • Awaiting test results may cause anxiety; support from healthcare providers is important.
  • Genetic counseling is recommended for understanding and coping with the diagnosis if mutations are found.

Pain management is typically not required, as the procedure is minimally invasive.

Medical Policies and Guidelines

Related policies from health plans